|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2011-1-24
|
|
pubmed:abstractText |
Previous studies suggest that tumor cells might be the progenitor for tumor vasculature. Whether vascular tube formation from transdifferentiation of human glioma stem/progenitor cells (hGSPCs) contribute to angiogenesis of gliomas remain largely uncertain.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1558-6804
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
7
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
141-52
|
|
pubmed:meshHeading |
pubmed-meshheading:20697979-Angiogenesis Inducing Agents,
pubmed-meshheading:20697979-Animals,
pubmed-meshheading:20697979-Biological Markers,
pubmed-meshheading:20697979-Cell Hypoxia,
pubmed-meshheading:20697979-Cell Proliferation,
pubmed-meshheading:20697979-Cell Shape,
pubmed-meshheading:20697979-Cell Transdifferentiation,
pubmed-meshheading:20697979-Endothelial Cells,
pubmed-meshheading:20697979-Fluorescent Antibody Technique,
pubmed-meshheading:20697979-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:20697979-Glioma,
pubmed-meshheading:20697979-Humans,
pubmed-meshheading:20697979-Mice,
pubmed-meshheading:20697979-Mice, Nude,
pubmed-meshheading:20697979-Neoplastic Stem Cells,
pubmed-meshheading:20697979-Neovascularization, Pathologic,
pubmed-meshheading:20697979-Side-Population Cells,
pubmed-meshheading:20697979-Transcription, Genetic,
pubmed-meshheading:20697979-Xenograft Model Antitumor Assays
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Glioma stem/progenitor cells contribute to neovascularization via transdifferentiation.
|
|
pubmed:affiliation |
Department of Neurosurgery, The 2nd Affiliated Hospital of Suzhou University, 1055 Sanxiang Road, Suzhou 215004, People's Republic of China.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
